Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Foreign Particulate Matter Testing in Transdermal Patches

Posted on By

SOP for Foreign Particulate Matter Testing in Transdermal Patches

Standard Operating Procedure for Foreign Particulate Matter Testing in Transdermal Patches

1) Purpose

To establish a standardized procedure for detecting and quantifying foreign particulate matter in transdermal patches to ensure product safety and quality.

2) Scope

This SOP applies to the quality control (QC) and quality assurance (QA) departments responsible for foreign particulate matter testing of transdermal patches.

3) Responsibilities

3.1 QC Analysts: Perform foreign particulate matter tests according to the procedure.
3.2 QA Personnel: Review and approve test results and ensure compliance with the SOP.
3.3 Production Personnel: Provide samples and relevant documentation for testing.
3.4 Regulatory Affairs: Ensure that the foreign particulate matter testing procedure complies with regulatory requirements.

See also  SOP for Recall Procedure for Transdermal Patches

4) Procedure

4.1 Preparation:

4.1.1 Collect samples of transdermal patches from the production batch as per the sampling plan.

4.1.2 Ensure all equipment used for foreign particulate matter testing is calibrated and in good working condition.

4.2 Foreign Particulate Matter Testing:
4.2.1 Sample Preparation:

4.2.1.1 Aseptically remove patches from their packaging.

4.2.1.2 Visually inspect the patches under suitable lighting conditions.

4.2.2 Test Execution:

4.2.2.1

Use a low-power microscope or magnifying lens to examine the surface of the patches for foreign particulate matter.

4.2.2.2 Document the presence, size, and type of any particulate matter observed.

4.2.2.3 If necessary, perform additional testing using appropriate analytical techniques (e.g., microscopic analysis, filtration).

See also  SOP for Annual Product Review in Transdermal Patches Production

4.2.3 Post-Test Evaluation:

4.2.3.1 Compile test results and compare them against predefined acceptance criteria.

4.2.3.2 Investigate any deviations or out-of-specification (OOS) results according to the relevant SOPs.

4.2.3.3 Document all observations and results accurately in the test records.

4.3 Acceptance Criteria:

4.3.1 Define acceptance criteria for foreign particulate matter based on regulatory guidelines and product specifications.

4.3.2 Ensure that the transdermal patches meet the defined criteria before they are approved for release.

4.4 Documentation:

4.4.1 Record all test results, including test conditions, observations, and outcomes.

4.4.2 Maintain records of equipment calibration and maintenance.

4.5 Review and Approval:

4.5.1 QA personnel review test results for compliance with acceptance criteria.

See also  Transdermal Patches: SOP for Root Cause Analysis in Transdermal Patches Production

4.5.2 Approve or reject batches based on test outcomes.

4.5.3 Ensure all documentation is complete and accurate before batch release.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control
QA: Quality Assurance
OOS: Out-of-Specification

6) Documents, if any

Foreign Particulate Matter Test Records
Calibration Records
Test Method Protocols
Batch Manufacturing Records

7) Reference, if any

USP Chapter 788: Particulate Matter in Injections
ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Preparation of Powders
Next Post: SOP for Preparation of Metered-Dose Inhalers (MDIs)

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version